Contact this trialFirst, we need to learn more about you.
Device
Digital Biomarker Validation for Diabetes
Recruiting1 award6 criteria
San Francisco, California
This trial is studying a digital biomarker, called the DNN score, to see if it can be used to screen for type 2 diabetes mellitus. The DNN score uses photoplethysmography (PPG) technology on the commercial smartphone camera. The trial's aim is to see if the DNN score is as accurate as a glycated hemoglobin (HbA1c) test in detecting diabetes.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.